Fenylefrin Aguettant 100 mikrogram/ml Injektions-/infusionsvätska, lösning

Country: Sweden

Language: Swedish

Source: Läkemedelsverket (Medical Products Agency)

Active ingredient:

fenylefrinhydroklorid

Available from:

Laboratoire Aguettant

ATC code:

C01CA06

INN (International Name):

phenylephrine

Dosage:

100 mikrogram/ml

Pharmaceutical form:

Injektions-/infusionsvätska, lösning

Composition:

fenylefrinhydroklorid 0,122 mg Aktiv substans

Prescription type:

Receptbelagt

Product summary:

Förpacknings: Injektionsflaska, 1 x 20 ml; Injektionsflaska, 10 x 20 ml

Authorization status:

Godkänd

Authorization date:

2020-02-17

Patient Information leaflet

                                1
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
FENYLEFRIN AGUETTANT 100 MICROGRAMS/ML SOLUTION FOR INJECTION/INFUSION
(REFERRED TO AS “FENYLEFRIN AGUETTANT” IN THIS LEAFLET)
phenylephrine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE
BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Fenylefrin Aguettant is and what it is used for
2.
What you need to know before you are given Fenylefrin Aguettant
3.
How Fenylefrin Aguettant is given
4.
Possible side effects
5.
How to store Fenylefrin Aguettant
6.
Contents of the pack and other information
1.
WHAT FENYLEFRIN AGUETTANT IS AND WHAT IT IS USED FOR
This medicine belongs to a group of adrenergic and dopaminergic
agents.
It is used to treat low blood pressure during anaesthesia.
2.
WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN FENYLEFRIN AGUETTANT
YOU WILL NOT RECEIVE FENYLEFRIN AGUETTANT:
-
if you are allergic to phenylephrine hydrochloride or any of the other
ingredients of this
medicine (listed in section 6);
-
if you suffer from severe high blood pressure, or peripheral vascular
disease (poor blood
circulation);
-
if you are taking a Monoamine Oxydase inhibitor (MAO) (or within 2
weeks of their
withdrawal), that is used to treat depression (such as iproniazide,
nialamide);
-
if you suffer from severe overactive thyroid gland (hyperthyroidism).
WARNINGS AND PRECAUTIONS
Talk to your doctor, pharmacist or nurse before you are given
Fenylefrin Aguettant:
-
if you are elderly;
-
if you are diabetic;
-
if you suffer from arterial hypertension;
-
if you have an overactive thyroid gland (uncontrolled
hyperthyroidism),
-
if you have blood vessels disease, such as arteriosclerosis (hardening
and thickening of the
walls of the blood vessels);

                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet English 18-02-2020
Public Assessment Report Public Assessment Report English 29-10-2020